FIELD: biotechnology; medicine.
SUBSTANCE: use of peptide is proposed, which contains glycinyl-arginyl-glycinyl-cysteine acid-threonyl-proline for restoration of previously lost visual acuity in a subject, which is a human or an animal suffering from non-exudative or dry age-related macular degeneration, or for protection of the optic nerve, retinal Muller cells, retinal neurons, or retinal pigment epithelium cells from damage due to increased intraocular pressure or degenerative retinal disease.
EFFECT: invention provides improvement of best corrected visual acuity (hereinafter – BCVA) in subjects with dry age-related macular degeneration, in particular BCVA was improved for 20 letters.
6 cl, 6 dwg, 5 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS | 2018 |
|
RU2815482C2 |
| METHOD FOR IMPROVING FUNCTIONAL RETINA ACTIVITY IN THE CASES OF ITS ABNORMALITY OF VARIOUS GENESIS | 2004 |
|
RU2279886C2 |
| INTEGRIN RECEPTOR ANTAGONISTS AND USE THEREOF | 2012 |
|
RU2721907C2 |
| VIRIONS OF AN ADENO-ASSOCIATED VIRUS WITH A VARIANT CAPSID AND METHODS FOR USING THEM | 2017 |
|
RU2742724C1 |
| VIRIONS OF ADENO-ASSOCIATED VIRUS WITH OPTIONAL CAPSID AND METHODS OF THEIR USE | 2012 |
|
RU2611202C2 |
| METHOD OF TREATING RETINOPATHY IN PREMATURITY AND RELATED RETINOPATHIC DISEASES | 2006 |
|
RU2403906C2 |
| ISOLATED POPULATIONS OF MYELOID-LIKE CELLS OF BONE MARROW AND METHODS OF TREATMENT WITH THEM | 2006 |
|
RU2418856C2 |
| DIPEPTIDYLPEPTIDASE-4 INHIBITORS FOR LOCAL OPHTHALMOLOGICAL TREATMENT OF NEURODEGENERATIVE RETINAL DISEASES | 2017 |
|
RU2744878C2 |
| VECTORS ENCODING ROD-DERIVED CONE VIABILITY FACTOR | 2012 |
|
RU2664673C2 |
| METHOD FOR MODELING TOXIC RETINOPATHY | 2004 |
|
RU2284582C2 |
